|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 68.5 USD | -1.62% |
|
-0.77% | -13.25% |
| Apr. 22 | Leerink Partners Adjusts Price Target on CVS Health to $87 From $88 | MT |
| Apr. 17 | CVS, Cigna, Humana, UnitedHealth - Congress wants to clean up PBMs |  |
WASHINGTON (Reuters) - The U.S. Justice Department's antitrust review of CVS Health Corp's planned purchase of Aetna Inc may conclude soon, a source familiar with the review said on Monday.
That said, arranging divestitures needed to resolve antitrust concerns in the proposed transaction takes time and it is not clear that possible approval will come in September, said the source.
The $69 billion deal was announced in December.
(Reporting by Diane Bartz; Editing by Tom Brown)
| 1st Jan change | Capi. | |
|---|---|---|
| -13.25% | 87.77B | |
| +18.01% | 82.08B | |
| +11.97% | 30.03B | |
| -8.50% | 17.08B | |
| -1.46% | 16.41B | |
| +4.44% | 12.37B | |
| +5.11% | 12.17B | |
| -31.05% | 11.89B | |
| +27.83% | 11.62B | |
| +8.18% | 10.85B |
CVS HEALTH CORPORATION 
